BELFAGEMED
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
31-08
abbreviated format · 31 days late
2025
31-12
Financial
Weakest financial yearnet -€19,542
The net result drops to -€19,542, the lowest from 2023 to 2025.
27-08
full format · 27 days late
2024
31-12
Financial
Highest result from 2023 to 2025net €16,293 ▲19.8%
The operating result of €22,309 and the net result of €16,293 are both a record.
19-08
full format · 19 days late
2023
13-06
Gazette deed
IncorporationStarting capital €3,000 · Appointment: JOLY Louise Laure Marie Elise (director) · Founder9 points ▸
Gazette deed
Incorporation
Starting capital €3,000 · Appointment: JOLY Louise Laure Marie Elise (director) · Founder9 points ▸
- Incorporation, “BELFAGEMED” (deed in French)
- Founder, JOLY Louise Laure Marie Elise
- Founding capital, €3,000
- Capital
- General meeting, “comparant, actionnaire unique, dépôt au greffe d'une expédition de l'acte constitutif” (deed in French)
- Registered office clause, “4052 Chaudfontaine, rue Toussaint Gerkens, 39/14B” (deed in French)
- Director appointment, JOLY Louise Laure Marie Elise (director (not named in the articles))
- Board rule, 1
- Pre-incorporation commitments, “takeover, engagements,obligations,activités dans délai légal au nom et pour compte société en formation” (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank